IBM-HashiCorp deal unde further scrutiny by UK antitrust regulator
[ad_1]
IBM-HashiCorp deal unde further scrutiny by UK antitrust regulator
[ad_2]
Similar Posts
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
Byadmin
[ad_1] Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer [ad_2]
Tungray Technologies says revenues for six months ended June 30 was $5.4M
Byadmin
[ad_1] Tungray Technologies says revenues for six months ended June 30 was $5.4M [ad_2]
EVgo expects to triple its charging network by 2029 with help from DofE and General Motors
Byadmin
[ad_1] EVgo expects to triple its charging network by 2029 with help from DofE and General Motors [ad_2]
Pharma lobby slams IRA, PBMs as Medicare lists 15 more drugs for price setting
Byadmin
[ad_1] Jan. 17, 2025 11:58 AM ETAMGN, GSK, BMY, PFE, NVO, MRK, TEVA, AZN, BHC, ALPMF, ALPMY, IRWD, ABBVBy: Dulan Lokuwithana, SA News Editor wildpixel/iStock via Getty Images As Medicare announced a fresh set of drugs selected for its price-setting process on Friday under the Inflation Reduction Act, industry group PhRMA criticized the landmark legislation,…
Italian PM Meloni denies discussing Starlink deal with Musk
Byadmin
[ad_1] Italian PM Meloni denies discussing Starlink deal with Musk [ad_2]
Davis Select International ETF declares annual distribution of $0.5100
Byadmin
[ad_1] Davis Select International ETF declares annual distribution of $0.5100 [ad_2]